Skip to main content
. Author manuscript; available in PMC: 2013 Jan 17.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2006 Aug;15(8):1443–1450. doi: 10.1158/1055-9965.EPI-06-0144

Table 6.

Association between selected characteristics and Ki-ras mutation and/or p53 overexpression

Characteristics Ki-ras and p53-negative (n = 701) Ki-ras or p53-positive (n = 154) Ki-ras and p53-positive (n = 17) P *
Age, y (SE) 66.1 (0.33) 66.5 (0.60) 67.8 (1.22) 0.04
Male (%) 67.3 68.4 69.5 0.75
Family history (%) 18.1 13.4 9.8 0.11
Previous polyp (%) 40.0 22.3 11.0 <0.0001
No. of adenomas (SE) 1.81 (0.05) 1.89 (0.08) 1.96 (0.17) 0.40
Rectal adenomas (%) 9.1 13.8 20.2 0.04
Size, mm (SE) 7.8 (0.23) 12.0 (0.41) 16.2 (0.84) <0.0001
HGD (%) 18.6 41.0 67.9 <0.0001
Tubulovillous/villous histology (%) 19.3 54.6 85.8 <0.0001
Advanced adenomas (%)§ 44.9 79.5 94.8 <0.0001
*

χ2 for categorical variables and P trends for continuous variables (adjusted for age and number of adenomas).

History of colorectal cancer in one or more first-degree relatives.

Self-reported history of polyps prior to baseline adenoma.

§

Includes one or more of the following characteristics: tubulovillous or villous histology, ≥1 cm in size, or HGD.